Skip to main content
. 2021 Mar 10;27(4):544–562. doi: 10.1111/hae.14282

TABLE 1.

PECOS criteria

Inclusion Exclusion
Participants
  • Human

  • All ages and nationalities

  • Diagnosis of mild/moderate/severe FVIII/FIX deficiency

  • Animal studies

  • In vitro studies

  • Other rare bleeding disorders

  • Von Willebrand's Disease

  • Acquired haemophilia

Exposures
  • +/‐ information on treatment regimen

  • PA or exercise interventions

Comparators
  • No comparators

  • Subgroup categories within study population (eg age or severity)

  • Control groups without haemophilia

  • PA guidelines

  • Comparators not specified in inclusion criteria

Outcomes
  • Any assessment of habitual PA (ie retrospective audit, observation, self‐reported measures and objective measures)

  • +/‐ information on bleeds (ie annualised joint bleed rate, other bleed scores, self or documented report of number/type/cause of bleed, etc.)

  • Outcomes not specified in inclusion criteria

Study design
  • Cross‐sectional, cohort and case‐control studies

  • Longitudinal/prospective follow‐up studies

  • Retrospective studies

  • Pilot studies

  • Pre/post‐interventional studies

  • Case reports

  • Systematic/narrative reviews

  • Conference abstracts/letters to the editor